← board
ASBP
distress 5/10 · elevated risk$7.55-3%today-68% from 52w high
Revenue
pre-revenue
Liquidity
$6M
Runway
0.8 yrs
Shares 1y
-97%
Price & events
+317.1% over 6M
CatalystRating changeDilutionFinancingdashed = today
-2.7%
1D
+20.2%
1W
+22.4%
1M
+3411.6%
3M
+300.5%
6M
-54.5%
1Y
-98.3%
2Y
—
5Y
-98.1%
All
Overview
- Market Cap
- $9.78M
- Volume
- 6.37K
- 52 Week Range
- $0.15 – $23.60
- Total Shares
- 1.30M
- Float Shares
- 1.22M
- Short %
- 7.89%
- % Held by Insiders
- 5.91%
- % Held by Institutions
- 0.99%
- RVOL
- 0.01x
- Beta
- 0.15
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 1,295,234 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.